Tonix Pharmaceuticals stock halted ahead of FDA approval news
FRANKFURT - Deutsche Bank AG (ETR:DBKGn), acting as the Stabilisation Coordinator, has announced the possibility of market stabilization activities in relation to Robert Bosch (NSE:BOSH) Investment Nederland B.V.’s upcoming bond issue. The stabilization period is expected to commence today and may extend until July 9, 2025.
The bond, issued by Robert Bosch Investment Nederland B.V. with a 12-year fixed term and an ISIN code of DE000A4EBMD9, is yet to have its aggregate nominal amount confirmed. The initial price thoughts are set around a spread of MS+170bps area.
A consortium of banks, including BNP PARIBAS, Commerzbank (ETR:CBKG), Deutsche Bank, LBBW, Mizuho (NYSE:MFG), and Santander (BME:SAN), have been appointed as Stabilising Managers. They may engage in transactions to support the market price of the securities at a level higher than might otherwise prevail. However, there is no certainty that stabilization will occur, and if initiated, it can be discontinued at any time.
Stabilization actions are intended to support a security’s market price during its launch period. These actions, including over-allotment of securities, are subject to strict regulations to prevent market manipulation and are conducted within the bounds of applicable laws.
The announcement clarifies that the securities are not being offered for sale in the United States and have not been registered under the United States Securities Act of 1933. As such, they cannot be sold in the U.S. without registration or an exemption from registration, and no public offer of the securities will be made in the United States.
This information, based on a press release statement, is directed at professional investors in the UK and qualified investors in the EEA and the UK, in line with respective regulations. It is not an invitation or offer to the general public to underwrite, subscribe for, or otherwise acquire or dispose of any securities. The London Stock Exchange (LON:LSEG)’s news service RNS, approved by the Financial Conduct Authority, has distributed this announcement. Terms and conditions related to the use and distribution of this information may apply.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.